Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Haymanti Bhanot"'
Autor:
Nana Chen, Gabriel Golczer, Subhoshree Ghose, Brian Lin, Adam Langenbucher, Jason Webb, Haymanti Bhanot, Nicholas B. Abt, Derrick Lin, Mark Varvares, Martin Sattler, Ann Marie Egloff, Richard Joh, Ravindra Uppaluri, Kevin S. Emerick, Michael S. Lawrence, Srinivas Vinod Saladi
Publikováno v:
Cell Reports, Vol 39, Iss 11, Pp 110970- (2022)
Summary: Analysis of The Cancer Genome Atlas and other published data of head and neck squamous cell carcinoma (HNSCC) reveals somatic alterations of the Hippo-YAP pathway in approximately 50% of HNSCC. Better strategies to target the YAP1 transcript
Externí odkaz:
https://doaj.org/article/13be6881b6a64f958b845f078f8a66c3
Autor:
Nana Chen, Gabriel Golczer, Subhoshree Ghose, Brian Lin, Adam Langenbucher, Jason Webb, Haymanti Bhanot, Nicholas B. Abt, Derrick Lin, Mark Varvares, Martin Sattler, Ann Marie Egloff, Richard Joh, Ravindra Uppaluri, Kevin S. Emerick, Michael S. Lawrence, Srinivas Vinod Saladi
Publikováno v:
Cell reports. 39(11)
Analysis of The Cancer Genome Atlas and other published data of head and neck squamous cell carcinoma (HNSCC) reveals somatic alterations of the Hippo-YAP pathway in approximately 50% of HNSCC. Better strategies to target the YAP1 transcriptional com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67b7b8182c1dff7583a2334601dfb1ef
https://pubmed.ncbi.nlm.nih.gov/35705032
https://pubmed.ncbi.nlm.nih.gov/35705032
Autor:
James D. Griffin, Haymanti Bhanot, Richard Stone, Ellen Weisberg, Donna Neuberg, Klaus Podar, Ravi Salgia, Atsushi Nonami, Martin Sattler, Mamatha M. Reddy
Publikováno v:
Oncotarget
// Haymanti Bhanot 1, 2 , Ellen L. Weisberg 1, 2 , Mamatha M. Reddy 1, 2, 7 , Atsushi Nonami 1, 2, 8 , Donna Neuberg 3 , Richard M. Stone 1, 2 , Klaus Podar 4, 5 , Ravi Salgia 6 , James D. Griffin 1, 2 and Martin Sattler 1, 2 1 Department of Medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c59abcb973bd41b8823e2b603205ee
https://doi.org/10.18632/oncotarget.18797
https://doi.org/10.18632/oncotarget.18797
Autor:
Rozenn Riou, Brian M. Lin, Srinivas Vinod Saladi, Nicholas B. Abt, Jayaraj Rajagopal, Haymanti Bhanot, Derrick T. Lin
Publikováno v:
Oral Oncology. 111:104930
Mutations in histone modifying enzymes and histone variants were identified in multiple cancers in The Cancer Genome Atlas (TCGA) studies. However, very little progress and understanding has been made in identifying the contribution of epigenetic fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11eb925b3a6cc005f79118ccff0cf023
https://doi.org/10.1016/j.oraloncology.2020.104930
https://doi.org/10.1016/j.oraloncology.2020.104930
Publikováno v:
Molecular Cancer Research. 8:1358-1374
Methuosis is a unique form of nonapoptotic cell death triggered by alterations in the trafficking of clathrin-independent endosomes, ultimately leading to extreme vacuolization and rupture of the cell. Methuosis can be induced in glioblastoma cells b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2b13aa4bc85f509c3d7dd3d03bf874
https://doi.org/10.1158/1541-7786.mcr-10-0090
https://doi.org/10.1158/1541-7786.mcr-10-0090
Publikováno v:
Molecular Cancer, Vol 10, Iss 1, p 69 (2011)
Molecular Cancer
Molecular Cancer
Background Methuosis is a unique form of non-apoptotic cell death triggered by alterations in the trafficking of clathrin-independent endosomes, ultimately leading to extreme vacuolization and rupture of the cell. Results Here we describe a novel cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215a6720fa5b3ebe5edcddc18b362faf
http://www.molecular-cancer.com/content/10/1/69
http://www.molecular-cancer.com/content/10/1/69
Autor:
Sabrina K. Salgia, Kelly Xing, James D. Griffin, Atsushi Nonami, Mamatha M. Reddy, Haymanti Bhanot, Ellen Weisberg, Martin Sattler, John M. Asara, Richard Stone
Publikováno v:
Blood. 122:1479-1479
Small molecule kinase inhibitors have dramatically changed treatment of patients with myeloid malignancies, in particular chronic myeloid leukemia (CML), myeloproliferative neoplasms and some acute myeloid leukemias (AML). Nevertheless, genomic insta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f51bf602536cc5d79ff7ef232dafd985
https://doi.org/10.1182/blood.v122.21.1479.1479
https://doi.org/10.1182/blood.v122.21.1479.1479